Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Finasteride and testosterone are the drugs most linked to male infertility, but many other potential drugs may be under-reported.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

FFA patients have higher metal levels in hair, possibly linked to product use.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Estrogen receptors affect hair growth, with ER beta slowing down the hair cycle changes caused by ER alpha.

Minoxidil and spironolactone improve hair density and reduce shedding in girls.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

The levels of zinc, vitamin D, ferritin, and selenium are different in people with androgenic alopecia compared to a control group.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Vitamin D receptor gene changes don't affect alopecia areata risk.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The research helps understand how finasteride works and aids drug development.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.